Denosumab biosimilar by Sandoz Group for Humoral Hypercalcemia of Malignancy: Likelihood of Approval

Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Humoral Hypercalcemia of Malignancy.

Future Outlook for Endometrial Cancer Trials, Treatment

In this exclusive MedPage Today video, Elizabeth Lee, MD, from the Dana-Farber Cancer Institute in Boston, offers some thoughts on how she believes endometrial cancer

November 23, 2023

MHRA unveils roadmap for new medical device regulations in the UK

MHRA sets out new plans to protect patient safety and enable access without delay for UK patients to innovative medical technologies.

January 13, 2024

How Aloe vera’s medicinal properties make it essential in medicine, cosmetics, and food products

Comprehensive review highlights Aloe vera’s versatile biological activities and its potential applications in medicine and cosmetics while addressing its safety concerns.

July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.